A new rapid molecular point-of-care assay for Trichomonas vaginalis: Preliminary performance data

Sexually Transmitted Infections

Volumn 89, Issue 6, 2013, Pages 495-497

  Pearce, David M ^a   Styles, David N ^a   Hardick, Justin P ^b   Gaydos, Charlotte A ^b  

^a Atlas Genetics Ltd   (United Kingdom)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; NUCLEIC ACID;

ARTICLE; ASSAY; CONTROLLED STUDY; CROSS REACTION; DNA ISOLATION; ELECTROCHEMICAL DETECTION; FEMALE; GENE AMPLIFICATION; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; POINT OF CARE TESTING; PRIORITY JOURNAL; PROTOZOAL GENETICS; SCREENING TEST; SENSITIVITY AND SPECIFICITY; TRICHOMONAS VAGINALIS; VAGINA SMEAR;

DIAGNOSIS; DNA AMPLIFICATION; TRICHOMONAS;

FEMALE; HUMANS; MALE; MOLECULAR DIAGNOSTIC TECHNIQUES; PARASITOLOGY; POINT-OF-CARE SYSTEMS; SENSITIVITY AND SPECIFICITY; TRICHOMONAS INFECTIONS; TRICHOMONAS VAGINALIS;

EID: 84884534595     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sextrans-2012-051000     Document Type: Article

References (12)

1. World Health Organisation (WHO). Global prevalence and incidence of selected sexually transmitted infections Chlamydia trachomatis, Neisseria gonorrhoeae, syphilis and Trichomonas vaginalis: methods and results used by WHO to generate 2005 estimates. Geneva: WHO, 2011.
2. McClelland RS, Sangaré L, Hassan WM, et al. Infection with Trichomonas vaginalis increases the risk of HIV-1 Acquisition. J Inf Dis 2007;195:698-702.
3. Cotch MF, Pastorek JG, Nugent RP, et al. Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis 1997;24:353-60. (Pubitemid 27306585)
4. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010;59:1-110.
5. Huppert JS, Mortensen JE, Reed JL, et al. Rapid antigen testing compares favorably with transcription-mediated amplification assay for the detection of Trichomonas vaginalis in young women. Clin Inf Dis 2007;45:194-8. (Pubitemid 47041010)
6. Huang W, Gaydos CA, Barnes MR, et al. Comparative effectiveness of a rapid point-of-care test for detection of Chlamydia trachomatis among women in a clinical setting. Sex Transm Inf 2013;89:108-14.
7. Pearce DM, Shenton DS, Holden J, et al. Evaluation of a novel electrochemical detection method for Chlamydia trachomatis: application for point-of-care diagnostics. IEEE Trans Biomed Eng 2011;58:755-8.
8. Andrea SB, Chapin KC. Comparison of Aptima Trichomonas vaginalis transcription-mediated amplification assay and BD Affirm VPIII for detection of T vaginalis in symptomatic women: performance parameters and epidemiological implications. J Clin Microbiol 2011;49:866-9.
9. Carlton JM, Hirt RP, Silva JC, et al. Draft genome sequence of the sexually transmitted pathogen Trichomonas vaginalis. Science 2007;315:207-12. (Pubitemid 46166360)
10. Hillier SC, Flower SE, Frost CG, et al. An electrochemical gene detection assay utilizing T7 exonuclease activity on complementary probe-target oligonucleotide sequences. Electrochem Commun. 2004;6:1227-32.
11. Bard AJ, Faulkner LR. Electrochemical methods: fundamentals and applications. 2nd edn. Hoboken, NJ: Wiley, 2001.
12. Hsieh Y-H, Hogan MT, Barnes M, et al. Perceptions of an ideal point-of-care test for sexually transmitted infections-A qualitative study of focus group discussions with medical providers. PLoS ONE 2010;5:e14144.